In the dynamic world of science and technology, Bruker Cellular Analysis is at the forefront, driving advancements in functional cell biology to improve human health. Our goal is to empower scientists to maximize the potential of every cell through pioneering optofluidic and proteomic technologies. We are excited to share our latest innovations and collaborations at two upcoming cell biology conferences.
Discovery on Target 2023 Conference
From September 25-27, 2023, the Discovery on Target 2023 conference in Boston will gather biotechnology experts to discuss novel drug targets and technologies.
Genovac, a Bruker Cellular Analysis partner, will lead a presentation on September 26, at 2:20 p.m. ET.
Andreas Weise, senior account manager at Genovac, will feature our Beacon® platform’s capabilities with a presentation titled “Enhance and Expand Anti-ID Antibody Diversity and Affinity Through Genetic Immunization.” This talk will discuss how Genovac identified and characterized highly diverse high-affinity anti-idiotypic antibodies that enable candidate therapeutic antibody PK/PD studies by leveraging their cutting-edge immunization strategies and world-class expertise in adapting new animal species onto Bruker Cellular Analysis’ optofluidic single B cell screening on the Beacon platform.
Annual Festival of Biologics Basel Conference & Exhibition
Heading to Basel, Switzerland, from October 10-12, 2023, we are excited to participate in The Festival of Biologics conference. This event serves as a hub for pharmaceutical, biotech, academic, and research organizations, with a focus on antibodies, immunotherapy, and biosimilars.
Visit us at booth #910 to experience our optofluidic and proteomic technologies firsthand. Explore demonstrations showcasing how Bruker Cellular Analysis’ products are transforming our understanding of cellular function, benefiting scientific discovery, bioprocessing, clinical research, and immunotherapy development.
One of our highlights will be a poster presentation titled “Rapid Discovery of Functional Human Memory B Cell-Derived Antibodies for SARS-CoV-2 Using the Beacon Optofluidic System.”
Additionally, don’t miss Jonathan Didier’s presentation on October 11, 2023, from 4:50 p.m. to 5:10 p.m. CET, titled, “Rapid Discovery of Clinically Relevant Antibodies using the Bruker Cellular Analysis Beacon.” Jonathan, a senior field applications scientist at Bruker Cellular Analysis, will unveil how our Opto® Plasma B Discovery Workflows on the Beacon optofluidic systems are revolutionizing antibody discovery workflows across different species, broadening sequence diversity to meet diverse research objectives.
Join us at these upcoming conferences as we shape the future of cell biology, bioprocessing, and immunotherapy development. Together, we’ll accelerate scientific progress and redefine the possibilities in functional cell biology.